INTERNATIONAL PATENT: THERATECHNOLOGIES INC., TRANSFERT PLUS, SOCIETE EN COMMANDITE FILES APPLICATION FOR "COMBINATION THERAPIES COMPRISING PEPTIDE-DRUG CONJUGATES TARGETING SORTILIN"

GENEVA, Oct. 12 -- THERATECHNOLOGIES INC. (2015 rue PeelBureau 1100Montreal, Quebec H3A 1T8), TRANSFERT PLUS, SOCIETE EN COMMANDITE (1405 boul. du Parc-TechnologiqueQuebec, Quebec G1P 4P5) filed a patent application (PCT/CA2025/050465) for "COMBINATION THERAPIES COMPRISING PEPTIDE-DRUG CONJUGATES TARGETING SORTILIN" on Apr 01, 2025. With publication no. WO/2025/208212, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEMEULE, Michel (504 Montrose DriveBeaconsfield, Quebec H9W 5W7), ANNABI, Borhane (8565 rue OffenbachBrossa...